The Latest Breaking News on Pharma

IRPC, the petrochemical arm of national oil and gas conglomerate PTT Plc, is preparing to buy new assets in the speciality polymer manufacturing segment as it steps up efforts to earn more revenue from high-margin products.

Republican Pennsylvania Senate candidate Dr. Mehmet Oz owns shares of two companies he publicly supported, touting their drugs as potential Covid-19 treatments — even though the drugs weren't approved by the U.S. Food and Drug Administration (FDA).

Chance to eradicate diseases such as malaria could be lost and UK innovation squandered if global health investment is cut, jab co-creator tells PM

PharmaTher Holdings (OTCQB: PHRRF), the biopharma company developing novel uses and delivery forms of ketamine for mental health treatments, has completed an IND-enabling pharmacokinetic and tolerability study of its ketamine patch, KETARX, in minipigs. 

Health department had denied Covid testing priority lane but new disclosure lists firms including lab behind false negatives

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Pfizer’s (NYSE:PFE) lead drug GBS6 or PF-06760805 for the prevention of invasive GBS disease due to the vaccine serotypes in newborns and young infants by active immunization of their mothers during pregnancy. Pfizer shares traded in a…

Even with new boosters, experts predict the scourge that’s already lasted longer than the 1918 flu pandemic will linger far into the future. Here’s why.

The Food and Drug Administration is holding an unusual second meeting to review a closely watched drug for the illness known as Lou Gehrig’s disease

E-cigarette producer Juul Labs agreed to pay $438.5 million to 34 states and territories to sort out a two-year bipartisan investigation into its marketing and sales practices.